Medicare Enrolled
Dr. Eric Lee, MD
Cardiovascular Disease · Glendale, CA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Eric Lee is a cardiovascular disease specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 4,501 Medicare services across 3,244 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $21,482 from 52 pharmaceutical and/or device companies across 865 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in CA
$21,482 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,501
Medicare services
Top 23% in CA for cardiovascular disease
3,244
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~237 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
990 | $67 | $147 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
783 | $101 | $280 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
341 | $174 | $584 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
312 | $12 | $45 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
295 | $5 | $31 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
237 | $24 | $86 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
178 | $20 | $55 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
178 | $131 | $360 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
172 | $148 | $408 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
129 | $17 | $69 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
129 | $12 | $46 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
127 | $111 | $278 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
88 | $68 | $221 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
81 | $21 | $58 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
78 | $11 | $34 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
66 | $100 | $211 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
54 | $29 | $128 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $142 | $392 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
38 | $51 | $195 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
26 | $60 | $903 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
22 | $56 | $182 |
| Cardiac catheterization | 21 | $207 | $905 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
21 | $10 | $202 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
17 | $2 | $10 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
16 | $14 | $47 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
13 | $12 | $138 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
13 | $21 | $90 |
| New patient office visit, complex (60-74 min) | 13 | $181 | $476 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
12 | $57 | $186 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $80 | $198 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.4% high complexity
7.5% medium
75.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,482
Total received (2018-2024)
Avg $3,069/year across 7 years
Top 16% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
865
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,340 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$142 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,304
2023
$2,880
2022
$2,659
2021
$2,676
2020
$2,675
2019
$3,530
2018
$2,757
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTRONIK NRO, Inc.
$1,885
Boehringer Ingelheim Pharmaceuticals, Inc.
$319
Merck Sharp & Dohme LLC
$229
Novartis Pharmaceuticals Corporation
$203
Kiniksa Pharmaceuticals International, plc
$178
AstraZeneca Pharmaceuticals LP
$167
Medtronic, Inc.
$164
PFIZER INC.
$159
Amgen Inc.
$151
Alnylam Pharmaceuticals Inc.
$133
Esperion Therapeutics, Inc.
$97
Boston Scientific Corporation
$72
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$70
ABIOMED
$60
Lexicon Pharmaceuticals, Inc.
$58
Edwards Lifesciences Corporation
$46
Philips North America LLC
$45
Novo Nordisk Inc
$38
HEARTFLOW, INC.
$35
SANOFI-AVENTIS U.S. LLC
$31
CVRx, Inc.
$31
AltaThera Pharmaceuticals LLC
$27
Lilly USA, LLC
$25
Actelion Pharmaceuticals US, Inc.
$24
HARMONY BIOSCIENCES LLC
$23
E.R. Squibb & Sons, L.L.C.
$18
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 56.5% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK NRO, Inc.
$2,058
Amgen Inc.
$1,837
Novartis Pharmaceuticals Corporation
$1,750
AstraZeneca Pharmaceuticals LP
$1,470
PFIZER INC.
$1,273
Boston Scientific Corporation
$1,137
Abbott Laboratories
$1,027
Medtronic Vascular, Inc.
$863
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$859
E.R. Squibb & Sons, L.L.C.
$820
Janssen Pharmaceuticals, Inc
$809
Boehringer Ingelheim Pharmaceuticals, Inc.
$696
Merck Sharp & Dohme LLC
$669
Edwards Lifesciences Corporation
$583
SANOFI-AVENTIS U.S. LLC
$489
Amarin Pharma Inc.
$418
Kowa Pharmaceuticals America, Inc.
$418
Medtronic, Inc.
$412
BOSTON SCIENTIFIC CORPORATION
$403
Actelion Pharmaceuticals US, Inc.
$367
Alnylam Pharmaceuticals Inc.
$345
Bayer HealthCare Pharmaceuticals Inc.
$331
BIOTRONIK INC.
$307
Esperion Therapeutics, Inc.
$248
ARBOR PHARMACEUTICALS, INC.
$221
Kiniksa Pharmaceuticals International, plc
$178
GENZYME CORPORATION
$125
Merck Sharp & Dohme Corporation
$123
ABIOMED
$103
CVRx, Inc.
$94
Arbor Pharmaceuticals, Inc.
$90
Lexicon Pharmaceuticals, Inc.
$81
Regeneron Healthcare Solutions, Inc.
$79
iRhythm Technologies, Inc.
$70
Astellas Pharma US Inc
$63
Impulse Dynamics (USA) Inc.
$63
ZOLL Circulation Inc
$60
Novo Nordisk Inc
$59
Cardiovascular Systems Inc.
$52
Philips Electronics North America Corporation
$46
Philips North America LLC
$45
Corium, LLC
$45
Daiichi Sankyo Inc.
$44
HEARTFLOW, INC.
$35
MEDICOMP INC
$31
Vifor Pharma, Inc.
$30
SCPHARMACEUTICALS INC.
$28
AltaThera Pharmaceuticals LLC
$27
Kiniksa Pharmaceuticals, Ltd.
$27
Lilly USA, LLC
$25
Otsuka America Pharmaceutical, Inc.
$25
HARMONY BIOSCIENCES LLC
$23
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMVUTTRA · AVEIR · AZURE XT DR MRI SURESCAN · Adlarity · Allura Xper FD 20 · Arcalyst · BIOTRONIK · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIAC MONITOR · CARDIOMEMS · CHANTIX · CONFIRM RX · CardioMEMS HF System · Corlanor · Coronary Orbital Atherectomy System · DAKLINZA · ELIQUIS · EMBLEM MRI S-ICD · EMPLICITI · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FUROSCIX · Fortify Assura · IBRANCE · INJECTAFER · Impella · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LEXISCAN · LINQ II · LIVALO · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · RESONATE · Repatha · Reveal LINQ · SAMSCA · SAPIEN 3 Ultra RESILIA · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SYNERGY · Saxenda · Sotalol Hydrochloride · Stivarga · TIVDAK · Temperature Management System · UPTRAVI · VERQUVO · Vascepa · Veltassa · WAINUA · WAKIX · WATCHMAN Access System · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
557
Per 100K population
5.7
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Lee performed 990 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $21,482 from 52 companies across 865 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other cardiologists in Glendale?
Dr. Lee's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Glendale
Browse cardiologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK NRO, Inc. Payments to Doctors
See all physicians who received payments from BIOTRONIK NRO, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology